MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone
Authors:
Open Access
- 22 May 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (22) , 18980-18996
Abstract
MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of boneKeywords
This publication has 56 references indexed in Scilit:
- MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancerOncogene, 2012
- The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancerOncogene, 2012
- MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinomaJournal of Experimental & Clinical Cancer Research, 2011
- A short-term in vivo model for giant cell tumor of boneBMC Cancer, 2011
- Osteoporosis: now and the futureThe Lancet, 2011
- Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomyJournal of Experimental & Clinical Cancer Research, 2010
- MicroRNA control of signal transductionNature Reviews Molecular Cell Biology, 2010
- A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humansJournal of Clinical Investigation, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- Functions of RANKL/RANK/OPG in bone modeling and remodelingArchives of Biochemistry and Biophysics, 2008